Pethidine 50 mg/ml, 2 ml and 50 mg/ml, 1 ml ampoules (DBL Pethidine): Supply issue resolved

Pfizer, the supplier of DBL Pethidine, have notified Pharmac that the out of stock for their registered product has been resolved.

3 August 2021

Pfizer have advised that stock of DBL Pethidine has been quality assured and is going out to wholesalers today. 

Pfizer notified the market of a shortage of their registered product. They sourced an alternative product through Max Health. This product is not registered in New Zealand and comes in a 10 ampoule pack and must be administered under section 29 of the Medicines Act.

Pethidine in the community setting

The Max Health product could not be used in a community setting because of the Misuse of Drugs Regulations 1977, section s26(2)(e). The section states that a pharmacy cannot have a container that has more than 5 ampoules of pethidine. We cannot change or amend these Regulations.  

Read the Regulations on legislation.govt.nz(external link) 

Hospitals can order pethidine from OneLink

There is ample supply of the Max Health product for hospital use. Orders can be placed with OneLink on:

Who to contact

Contact Pfizer on their customer service number 0800 736 363